Late-Onset Drug Fever Associated with Minocycline: Case Report and Review of the Literature

Pharmacotherapy

Volumn 23, Issue 12 I, 2003, Pages 1659-1662

  Grim, Shellee A ^a   Romanelli, Frank ^b   Jennings, Patricia R ^c   Ofotokun, Ighovwerha ^d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Kentucky   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug fever; Minocycline

Indexed keywords

ADAPALENE; ANTICONVULSIVE AGENT; AZITHROMYCIN; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA LACTAM ANTIBIOTIC; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; DOXYCYCLINE; LANSOPRAZOLE; MINOCYCLINE; NARCOTIC AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE;

ADOLESCENT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; DRUG EXPOSURE; DRUG FEVER; DRUG WITHDRAWAL; EOSINOPHILIA; FATIGUE; HUMAN; HYPERSENSITIVITY; LUNG INFILTRATE; MALAISE; MALE; MYALGIA; WEIGHT GAIN; WEIGHT REDUCTION;

ACNE VULGARIS; ADOLESCENT; ANTI-BACTERIAL AGENTS; FEVER; HUMANS; MALE; MINOCYCLINE; TIME FACTORS;

EID: 0344011131     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.15.1659.31966     Document Type: Article

References (17)

1. Zouboulis CC, Piquero-Martin J. Update and future of systemic acne treatment. Dermatology 2003;206:37-53.
2. McEvoy GK, ed. Tetracyclines. In: AHFS drug information 2003. Bethesda, MD: American Society of Health-System Pharmacists, 2003:437-8.
3. Gorard DA. Late-onset drug fever associated with minocycline. Postgrad Med J 1990;66:404-5.
4. Kaufmann D, Pichler W, Beer JH. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne. Arch Int Med 1994;154:1983-4.
5. Elkayam O, Yaton M, Caspi D. Minocycline-induced arthritis associated with fever, livedo reticularis, and pANCA. Ann Rheum Dis 1996;55:769-71.
6. Kettaneh A, Fain O, Ziol M, et al. Minocycline-induced systemic adverse reaction with liver and bone marrow granulomas and Sézary-like cells. Am J Med 2000;108:353-4.
7. MacNeil M, Haase DA, Tremaine R, Marrie TJ. Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline. Am Acad Dermatol 1997;36:347-50.
8. Angulo JM, Sigal LH, Espinoza LR. Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis. Semin Arthritis Rheum 1998;28:187-92.
9. Otero M, Goodpasture HC. Pulmonary infiltrates and eosinophilia from minocycline [letter]. JAMA 1983;250:2602.
10. Piperano D, Donne C, Loire R, Cordier JF. Bronchiolitis obliterans organizing pneumonia associated with minocycline use: a possible cause. Eur Respir J 1995;8:1018-20.
11. Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline. Arch Dermatol 1996;132:934-9.
12. Somech R, Arav-Boger R, Assia A, Spirer Z, Jurgenson U. Complications of minocycline therapy for acne vulgaris: case reports and review of the literature. Pediatr Dermatol 1999;16(6):469-72.
13. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
14. Chosidow O, Poli F, Naline E, Advenier C, Revuz J. Comedonal diffusion of minocycline in acne. Dermatology 1998;196:162.
15. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997;133:1224-30.
16. Johnson DH, Cunha BA. Drug fever. Infect Dis Clin North Am 1996;10(1):85-91.
17. Cunha BA. Antibiotic side effects. Med Clin North Am 2001;85(1):149-85.